Startup Street: Hasura raises $100 million in Series C funding, enters unicorn club-March 2024-www.financetom.com

Startup Street: Hasura raises $100 million in Series C funding, enters unicorn club

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Startup Street: Hasura raises $100 million in Series C funding, enters unicorn club

Feb 25, 2022 12:10 PM

Open source startup Hasura has become the 10th startup to turn unicorn this year. The venture raised USD 100 million in funding round led by GreenOaks with participation from existing investors Nexus Venture Partners, Lightspeed Venture Partners and Vertex Ventures.

The Series C round brings the total capital raised by Hasura to USD 136.5 million and the company's valuation to USD 1 billion. To discuss about the road ahead CNBC-TV18 spoke to Tanmai Gopal, Co-Founder & CEO of Hasura.

Also Amarjit Batra, MD of Spotify India discusses company's India journey and road ahead.

Watch accompanying video for entire discussion.

Previous page： USTR extends some Chinese tariff exclusions, but many to fall away Next page： Atlassian Insider Sold Shares Worth $1,401,350, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

USTR extends some Chinese tariff exclusions, but many to fall away

May 24, 2024

WASHINGTON (Reuters) - The U.S. Trade Representative's (USTR) office on Friday announced a further extension of all China Section 301 tariff exclusions on 352 Chinese import and 77 pandemic-related categories through June 14, and said some would be extended through May 31, 2025. WHY IT'S IMPORTANT The administration of former President Donald Trump used Section 301 of the Trade Act...

Atlassian Insider Sold Shares Worth $1,401,350, According to a Recent SEC Filing

May 24, 2024

05:51 PM EDT, 05/24/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on May 24, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,401,350. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 185,148 shares of the company, with 185,148 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024004396/xslF345X03/primarydocument.xml Price: 168.75, Change: -0.11, Percent...

Molina Healthcare Insider Sold Shares Worth $3,451,480, According to a Recent SEC Filing

May 24, 2024

05:36 PM EDT, 05/24/2024 (MT Newswires) -- James Woys, Chief Operating Officer, on May 22, 2024, sold 10,000 shares in Molina Healthcare ( MOH ) for $3,451,480. Following the Form 4 filing with the SEC, Woys has control over a total of 53,613 shares of the company, with 53,613 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1179929/000117992924000095/xslF345X03/wk-form4_1716586439.xml Price: 333.00, Change: +0.87, Percent...

US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients

May 24, 2024

May 24 (Reuters) - Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of low blood sugar. The Food and Drug Administration's panel of independent experts voted 7-to-4, saying the weekly insulin icodec's benefits do not outweigh the risks Novo is aiming to...